News | Computed Tomography (CT) | October 24, 2020

AI-powered premium large bore CT scanner offers industry’s largest bore and widest field-of-view

AI-powered premium large bore CT scanner offers industry’s largest bore and widest field-of-view

October 24, 2020 — An estimated 1.8 million new cancer cases will be diagnosed in the U.S. this year alone. With a disease so prevalent, treatments like radiation therapy are critical, and while planning, clinicians require accuracy, precision and speed. Giving clinicians the opportunity to see more during radiation therapy planning, Canon Medical Systems USA, Inc. is introducing the Aquilion Exceed LB CT system (pending 510(k) clearance) during this year’s virtual American Society for Radiation Oncology (ASTRO) Annual Meeting.

The Aquilion Exceed LB can help Radiation Oncologists with fast and efficient radiation oncology workflows without compromising on patient position, image quality, or reproducibility. Features include:

  • Accuracy in even the most complex simulations through industry-leading capabilities, like the largest bore opening (90 cm), edge-to-edge extended Field-of-View (90 cm) reconstruction and widest detector coverage (4 cm).
  • Better contouring using Artificial Intelligence (AI) with sharp, clear and distinct images from Canon Medical’s Advanced intelligent Clear-IQ Engine (AiCE) Deep Learning Reconstruction (DLR) technology.
  • Expanded capabilities – because of the Aquilion Exceed LB’s suite of premium CT capabilities, the system is positioned for shared services to enable high-quality treatment follow-up and interventional procedures.

“Accurate simulation across even the most challenging treatment plans is imperative during radiation therapy planning,” said Erin Angel, managing director, CT Business Unit, Canon Medical Systems USA, Inc. “At Canon Medical, we deliver solutions that meet providers’ needs but also push the boundaries of traditional simulation. With the Aquilion Exceed LB, we brought deep learning reconstruction to the CT simulation space. This will revolutionize care for cancer patients and give the radiation oncology team the confidence and precision they need for accurate planning across patients.”

Learn more about Canon Medical’s new Exceed LB CT system by visiting our virtual booth during ASTRO, October 23 – 29, 2020.

For more information: us.medical.canon


Related Content

News | Breast Imaging

Nov. 17, 2025 — RadNet, Inc. and its wholly owned subsidiary, DeepHealth have announced results from the largest real ...

Time November 17, 2025
arrow
News | Radiology Business

Nov. 13, 2025 — Covera Health recently announced that Advanced Radiology Services (ARS) has joined its national Quality ...

Time November 17, 2025
arrow
News | Radiology Imaging

Nov. 13, 2025 — Medical imaging AI company Avicenna.AI has launched AVI, a new platform that delivers AI results ...

Time November 13, 2025
arrow
News | Interventional Radiology

Nov. 12, 2025 — On Nov. 11, Huntsman Cancer Institute at the University of Utah (the U) opened its first specialized ...

Time November 13, 2025
arrow
News | Radiology Business

Nov. 12, 2025 — Siemens has announced plans to deconsolidate its remaining stake in Siemens Healthineers (currently ...

Time November 13, 2025
arrow
News | Radiopharmaceuticals and Tracers

Nov. 11, 2025 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has released a position paper outlining ...

Time November 12, 2025
arrow
News | Prostate Cancer

Nov. 10, 2025 — Researchers at Wayne State University and the Barbara Ann Karmanos Cancer Institute have developed a ...

Time November 11, 2025
arrow
News | RSNA 2025

Nov. 7, 2025 — Coreline Soft will introduce its chest AI platform AVIEW 2.0 at RSNA 2025 (Nov. 30 – Dec. 4, Chicago) ...

Time November 10, 2025
arrow
News | Lung Imaging

Nov. 3, 2025 — RevealDx, a leader in the characterization of lung nodules, has introduced MDR Certification of RevealAI ...

Time November 07, 2025
arrow
News | Artificial Intelligence

Nov. 6, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, recently announced that Volpara ...

Time November 07, 2025
arrow
Subscribe Now